Updated:
Xiamen Kingdomway Group Co
Xiamen Kingdomway Group was founded in November 1997 by Jiang Bin and went public on the Shenzhen Stock Exchange in October 2011 (ticker 002626).
Xiamen Kingdomway Group Co
Xiamen Kingdomway Group was founded in November 1997 by Jiang Bin and went public on the Shenzhen Stock Exchange in October 2011 (ticker 002626). The company originated as a manufacturer of coenzyme Q10 and NMN under China's National Torch Program, later expanding into a vertically integrated health-products group. The firm operates across three layers: upstream bio-synthesis of active ingredients (coenzyme Q10, NMN, astaxanthin, ergothioneine), midstream manufacturing of finished dietary supplements, and downstream direct-to-consumer brand sales. Kingdomway owns five major supplement brands: Doctor's Best, Labrada, ProSupps, Wukun, and its namesake Jin Dawei. The company also holds minority stakes in iHerb, Beijing Huaguan, and Huatai Ruihe. Its geographic footprint spans production in China with distribution across North America, Europe, and Asia. Total assets exceeded ¥7.9B (approximately $1.1B) as of the 2024 annual report; the company employed roughly 3,200 people as of 2023. In September 2025, Kingdomway completed a convertible bond issuance on the Shenzhen Stock Exchange (per company filing, September 2025). The firm also maintains a philanthropic arm under its corporate social responsibility umbrella. As a listed company, Kingdomway operates with corporate governance distinct from a family office — it reports quarterly financials and is subject to securities regulation. The founding Jiang family retains control through a concentrated ownership stake, blending public-market accountability with family-led strategic direction.
General information
Firm type
Asset Manager
Year founded
1997
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Xiamen
Corporate office
Xiamen, China
Principals
江斌 (Jiang Bin)
董事长 (Chairman)
Sector focus
Frequently asked questions
Who controls Xiamen Kingdomway Group?
The company is publicly traded on the Shenzhen Stock Exchange (ticker 002626) and chaired by founder Jiang Bin. The Jiang family holds a controlling stake through direct and affiliated shareholdings, though the precise ownership percentage fluctuates with market transactions (per public filings, 2024).
How does Kingdomway source proprietary deal flow?
Kingdomway primarily grows through internal R&D and acquisitions of supplement brands. It has acquired Doctor's Best, Labrada, and ProSupps, and holds minority stakes in iHerb and other health players. Deal flow comes from industry relationships and strategic fit within its vertical manufacturing and distribution chain.
Is Kingdomway structured as a family office or a corporation?
It is a publicly listed corporation, not a family office. The founding Jiang family directs strategy from the chairman seat, but the entity reports quarterly earnings and is subject to Chinese securities law. This gives it a governance hybrid — public accountability with family-led control.
What investment stages does Kingdomway typically target?
Kingdomway targets mature supplement brands and minority stakes in e-commerce distribution platforms (e.g., iHerb). It does not operate as a venture investor; its acquisitions are typically established consumer-health brands with existing revenue and distribution.
Which sectors does Kingdomway explicitly avoid?
Kingdomway focuses exclusively on health supplements and bio-synthesis — it avoids pharmaceuticals, medical devices, or financial services. Its product portfolio centers on nutraceuticals such as coenzyme Q10, NMN, astaxanthin, and ergothioneine.
How is Kingdomway related to Doctor's Best, Labrada, and ProSupps?
These are wholly owned subsidiary brands under Kingdomway Group; each is a separate operating company with its own management, but all are consolidated into Kingdomway's financial reports. Doctor's Best is the largest brand by revenue, particularly strong in the US via Amazon and retail channels.
Does Kingdomway maintain philanthropic structures, and how are they separated?
The company's website lists corporate social responsibility initiatives, but it does not disclose a separate foundation or charitable trust. Philanthropic activities appear integrated into the corporation rather than housed in a distinct entity (per company website, 2026).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: